Our Research Digests

Welcome to the 97th edition of the Research Digest. July’s edition features ME/CFS studies that assess the potential diagnostic markers for ME/CFS and an article suggesting the immune and metabolic responses to intestinal cell damage are suppressed, in those living with ME/CFS. July’s edition also highlights Emerge Australia’s CEO Anne Wilson, and her focus on empowering change, for invisible illnesses.

Welcome to the 96th edition of the Research Digest. This month’s edition presents study outcomes demonstrating the presence of POTS in ME/CFS and further evidence that implicates the dysregulation of cytokine signalling in ME/CFS. This month’s Research Digest also highlights Emerge Australia’s efforts alongside members of the ME/CFS community and key stakeholders, to launch the Parliamentary Friends Group for ME/CFS, a meeting that took place at Parliament House on June 13th, 2023.

Welcome to the 95th edition of the Research Digest. This edition features a study looking at transcriptomic changes in those with ME/CFS following an exercise challenge and examines ME/CFS symptom differences in Black and White individuals. This edition also highlights the impact of long COVID in Australia and the Conversation hour discusses long COVID, in the context of how it’s changing the way we respond to ME/CFS.

Welcome to the 94th edition of the Research Digest. This month’s edition summarises research studies investigating the impact of exercise on post-exertional malaise, offering invaluable insights into exercise pathophysiology for both ME/CFS and long COVID. This month’s edition also highlights the long-awaited report from the parliamentary inquiry into long COVID, which includes a recommendation for more research and patient support for those living with ME/CFS.

Welcome to the 93rd edition of the Research Digest. This month’s edition summarises research that investigates factors that influence the prognosis of ME/CFS and demonstrates that high muscle sodium content, maybe a contributing factor to the pathophysiology of ME/CFS. A review is also highlighted that conveys what is presently known about long COVID and finally, a local study sheds light on brain structure changes that are common to long COVID and ME/CFS.

Welcome to the 92nd edition of the Research Digest. This month recapitulates research studies that extend our understanding of ME/CFS and long COVID. The effect of exercise on the content of extracellular vesicles is investigated for ME/CFS and for long COVID symptoms. This edition also highlights comments made by Professor Brendan Crabb, CEO of the Burnet Institute encouraging the government to ‘change the narrative’ to prevent the infection of COVID-19 and limit the impact of long COVID.

Welcome to the 91st edition of the Research Digest.  In our final edition for the year, a study evaluating aspects of the current IOM criteria is presented, as well as national and international research findings concerning Long Covid.   The final edition also puts a spotlight on the disbelief that people living with invisible disabilities like ME/CFS and Long Covid endure, and highlights Anne Wilson’s call for the government to better recognise those living with invisible disabilities.

Welcome to the 90th edition of the Research Digest. This month’s edition features ME/CFS studies investigating microclotting and antibody targeting of gut bacteria. Also presented, is the study of serum samples from post-covid syndrome and -/+ME/CFS patients, to further study endothelial dysfunction and the role of angiogenesis in both study groups. And finally, the recent ABC news article featuring Chris Armstrong and Anne Wilson is highlighted.

Welcome to the 89th edition of the Research Digest. This edition features a study looking more closely at blood cells to investigate mitochondrial abnormalities and immunological changes in ME/CFS. Furthermore, the effect of whole-body cryotherapy and activity monitoring in patients living with ME/CFS is presented. A link to Anne Wilson’s (Emerge Australia’s CEO) interview, responding to the lack of funding for ME/CFS and long COVID services in the federal budget is also highlighted.

Welcome to the 88th edition of the Research Digest. This edition features a study that aimed to determine the value of a simple, objective office-based test in the evaluation of OI and brain fog and large genetic association study that sought to identify chromosomal regions that may be linked to ME/CFS.

Welcome to the 87th edition of the Research Digest. This month’s edition highlights emerging evidence of endothelial dysfunction, to further demonstrate the striking similarities of Long Covid to ME/CFS. The metabolism of tryptophan and the role of its metabolites are also presented and postulated to influence symptoms of ME/CFS, as well as suggested mechanisms that may be responsible for the neuroinflammation observed in both ME/CFS and Long Covid.

Welcome to the 86th edition of the Research Digest. This edition reviews research articles looking further into infectious mononucleosis and its links with ME/CFS and the impact of ME/CFS, on the quality of life for patients and their partners.  The digest also presents a recent ME/CFS brain imaging study that may prove useful diagnostically in the future and highlights the 2GB radio interview, featuring Emerge Australia’s CEO Anne Wilson, discussing the impact of changes to Telehealth.

Welcome to the 85th edition of Emerge Australia’s Research Digest. As a special edition, this month’s digest recapitulates Emerge Australia’s ME/CFS Awareness Week Research Panel webinar, providing insight into how our local ME/CFS community is contributing to ME/CFS research in Australia; via their contributions to the ME/CFS Biobank and You+ME Registry Australia.

Welcome to the Research Digest’s 84th edition. This month we recap research studies of ME/CFS endothelial cell dysfunction and how metabolomics may provide insight into ME/CFS, pre-and post-exercise. Also presented, is advice for the treatment of Long Covid patients, given the injustices experienced by those with ME/CFS and a very honest account of what lengths a person living with ME/CFS will go to, in the absence of ME/CFS treatments; accenting the dire need for vital ME/CFS research funding.